Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Development and validation of novel clinical endpoints in intermediate age-related macular degeneration in MACUSTAR].
Terheyden JH, Finger RP, Schmitz-Valckenberg S, Agostini H, Dahlke C, Kuehlewein L, Lang GE, Pauleikhoff D, Wolf A, Boettger MK, Luhmann UFO, Asmus F, Holz FG; MACUSTAR-Konsortium. Terheyden JH, et al. Among authors: asmus f. Ophthalmologe. 2019 Dec;116(12):1186-1193. doi: 10.1007/s00347-019-0907-1. Ophthalmologe. 2019. PMID: 31087116 Review. German.
MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration.
Finger RP, Schmitz-Valckenberg S, Schmid M, Rubin GS, Dunbar H, Tufail A, Crabb DP, Binns A, Sánchez CI, Margaron P, Normand G, Durbin MK, Luhmann UFO, Zamiri P, Cunha-Vaz J, Asmus F, Holz FG; on behalf of the MACUSTAR consortium. Finger RP, et al. Among authors: asmus f. Ophthalmologica. 2019;241(2):61-72. doi: 10.1159/000491402. Epub 2018 Aug 28. Ophthalmologica. 2019. PMID: 30153664 Free PMC article. Review.
Impact of Baseline Retinal Nonperfusion and Macular Retinal Capillary Nonperfusion on Outcomes in the COPERNICUS and GALILEO Studies.
Feltgen N, Ogura Y, Boscia F, Holz FG, Korobelnik JF, Brown DM, Heier JS, Stemper B, Rittenhouse KD, Asmus F, Ahlers C, Vitti R, Saroj N, Mitchell P. Feltgen N, et al. Among authors: asmus f. Ophthalmol Retina. 2019 Jul;3(7):553-560. doi: 10.1016/j.oret.2019.02.010. Epub 2019 Feb 27. Ophthalmol Retina. 2019. PMID: 31277796 Free article. Clinical Trial.
Integrated results from the COPERNICUS and GALILEO studies.
Pielen A, Clark WL, Boyer DS, Ogura Y, Holz FG, Korobelnik JF, Stemper B, Asmus F, Rittenhouse KD, Ahlers C, Vitti R, Saroj N, Zeitz O, Haller JA. Pielen A, et al. Among authors: asmus f. Clin Ophthalmol. 2017 Aug 23;11:1533-1540. doi: 10.2147/OPTH.S140665. eCollection 2017. Clin Ophthalmol. 2017. PMID: 28883712 Free PMC article.
Intravitreal Combined Aflibercept + Anti-Platelet-Derived Growth Factor Receptor β for Neovascular Age-Related Macular Degeneration: Results of the Phase 2 CAPELLA Trial.
Heier JS, Wykoff CC, Waheed NK, Kitchens JW, Patel SS, Vitti R, Perlee L, Chu KW, Leal S, Asmus F, Son V, Schmelter T, Brown DM. Heier JS, et al. Among authors: asmus f. Ophthalmology. 2020 Feb;127(2):211-220. doi: 10.1016/j.ophtha.2019.09.021. Epub 2019 Sep 25. Ophthalmology. 2020. PMID: 31791663 Clinical Trial.
Reply.
Ikuno Y, Ohno-Matsui K, Wong TY, Korobelnik JF, Vitti R, Li T, Stemper B, Asmus F, Zeitz O, Ishibashi T. Ikuno Y, et al. Among authors: asmus f. Ophthalmology. 2016 Feb;123(2):e17-e18. doi: 10.1016/j.ophtha.2015.08.046. Ophthalmology. 2016. PMID: 26802720 No abstract available.
68 results